A Study of Brenipatide in Participants With Alcohol Use Disorder

NCT07219953 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1100

Enrollment

INDUSTRY

Sponsor class

Conditions

Alcohol Use Disorder

Interventions

DRUG: LY3537031
DRUG: Placebo

Sponsor

Eli Lilly and Company